Informations générales (source: ClinicalTrials.gov)
Monitoring of Sleepiness in Patients With Parkinson's Disease Before and During Treatment With Continuous Dopaminergic Delivery Device or Deep Brain Stimulation
Observational
Central Hospital, Nancy, France (Voir sur ClinicalTrials)
juin 2020
juin 2023
29 juin 2024
Sleepiness is frequent in parkinsonian patients, increasing with the duration of disease.
By patients with motor fluctuations, continuous dopaminergic delivery devices or deep
brain stimulation are justified to improve the motor prognosis. Antiparkinsonian
treatments, especially dopaminergic agonists, may worsen the sleepiness and thus affect
the quality of life. The investigators aimed to monitor sleepiness in parkinsonian
patients before and during treatment with continous dopaminergic delivery device or deep
brain stimulation.
Etablissements
| Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| Nancy University Hospital - 54000 - Nancy - France | Nicolas Carpentier | Contact (sur clinicalTrials) | |||
Critères
Tous
Inclusion Criteria:
- patient with Parkinson's disease and motor fluctuations
- and indicated for a continuous dopaminergic delivery device or deep brain
stimulation
- patient with Parkinson's disease and motor fluctuations
- and indicated for a continuous dopaminergic delivery device or deep brain
stimulation
- age < 18 years
- refusal for the continuous dopaminergic delivery device or deep brain stimulation
- wake-promoting drugs intake
- refusal to participate
- legal protection
- uncontrolled sleep apnea